argenx reports positive phase 3 ADAPT SERON results of VYVGART in AChR-Ab seronegative gMG
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
This project shall be implemented through incorporation of a new joint venture company in Zambia
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Inclacumab was generally well tolerated in THRIVE-131
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
The inspection concluded with NIL observations
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
Subscribe To Our Newsletter & Stay Updated